 Matthew Babcock
Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sodium Chloride, Dietary | 8 | 2023 | 30 | 2.830 |
Why?
| | Baroreflex | 6 | 2022 | 54 | 1.890 |
Why?
| | Sympathetic Nervous System | 8 | 2023 | 171 | 1.830 |
Why?
| | Blood Pressure | 14 | 2023 | 1531 | 1.780 |
Why?
| | Exercise | 12 | 2023 | 1642 | 1.410 |
Why?
| | Diet, Sodium-Restricted | 3 | 2020 | 34 | 1.390 |
Why?
| | Testosterone | 3 | 2022 | 341 | 1.390 |
Why?
| | Vasodilation | 2 | 2020 | 418 | 1.140 |
Why?
| | Endothelium, Vascular | 3 | 2022 | 830 | 1.060 |
Why?
| | Brachial Artery | 4 | 2020 | 176 | 0.960 |
Why?
| | Hemodynamics | 4 | 2021 | 1015 | 0.860 |
Why?
| | Sodium, Dietary | 2 | 2021 | 36 | 0.860 |
Why?
| | Arterial Pressure | 2 | 2020 | 99 | 0.810 |
Why?
| | Pressoreceptors | 2 | 2021 | 18 | 0.790 |
Why?
| | Post-Exercise Hypotension | 1 | 2020 | 1 | 0.700 |
Why?
| | Hyperemia | 1 | 2020 | 45 | 0.700 |
Why?
| | Aging | 4 | 2022 | 1611 | 0.660 |
Why?
| | Vagus Nerve | 1 | 2018 | 79 | 0.590 |
Why?
| | Vascular Resistance | 1 | 2019 | 340 | 0.580 |
Why?
| | Young Adult | 18 | 2023 | 10444 | 0.550 |
Why?
| | Cross-Over Studies | 8 | 2023 | 439 | 0.530 |
Why?
| | Water Deprivation | 3 | 2020 | 8 | 0.510 |
Why?
| | Carotid Artery, Common | 1 | 2015 | 29 | 0.500 |
Why?
| | Rest | 1 | 2015 | 103 | 0.490 |
Why?
| | Bicycling | 2 | 2016 | 86 | 0.480 |
Why?
| | Heart | 1 | 2018 | 613 | 0.460 |
Why?
| | Cerebrovascular Circulation | 4 | 2021 | 219 | 0.460 |
Why?
| | Heart Rate | 7 | 2023 | 710 | 0.460 |
Why?
| | Physical Exertion | 1 | 2014 | 209 | 0.440 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 1726 | 0.430 |
Why?
| | Carotid Arteries | 1 | 2014 | 180 | 0.430 |
Why?
| | Adult | 17 | 2022 | 30375 | 0.410 |
Why?
| | Ventricular Function, Left | 1 | 2015 | 477 | 0.400 |
Why?
| | Blood Flow Velocity | 5 | 2022 | 388 | 0.390 |
Why?
| | Hypertension | 1 | 2019 | 1052 | 0.370 |
Why?
| | Vascular Stiffness | 1 | 2015 | 410 | 0.360 |
Why?
| | Heart Ventricles | 1 | 2015 | 723 | 0.350 |
Why?
| | Male | 21 | 2023 | 55396 | 0.340 |
Why?
| | Sodium | 3 | 2020 | 184 | 0.340 |
Why?
| | Ultrasonography, Doppler | 2 | 2022 | 104 | 0.310 |
Why?
| | Saline Solution, Hypertonic | 2 | 2018 | 39 | 0.300 |
Why?
| | Double-Blind Method | 3 | 2020 | 1656 | 0.290 |
Why?
| | Sex Characteristics | 2 | 2023 | 636 | 0.280 |
Why?
| | Humans | 30 | 2023 | 114045 | 0.280 |
Why?
| | Aged | 7 | 2022 | 18969 | 0.250 |
Why?
| | Hand Strength | 2 | 2023 | 97 | 0.240 |
Why?
| | Hypocapnia | 2 | 2021 | 6 | 0.230 |
Why?
| | Reflex | 2 | 2023 | 63 | 0.230 |
Why?
| | Female | 18 | 2023 | 59324 | 0.220 |
Why?
| | Middle Cerebral Artery | 2 | 2020 | 36 | 0.210 |
Why?
| | Chemokine CCL2 | 1 | 2023 | 104 | 0.210 |
Why?
| | Norepinephrine | 2 | 2021 | 201 | 0.210 |
Why?
| | Time Factors | 4 | 2020 | 6077 | 0.200 |
Why?
| | Healthy Volunteers | 3 | 2020 | 191 | 0.200 |
Why?
| | Regional Blood Flow | 2 | 2020 | 421 | 0.190 |
Why?
| | Plethysmography | 1 | 2022 | 103 | 0.190 |
Why?
| | Muscle, Skeletal | 3 | 2023 | 1468 | 0.190 |
Why?
| | Osmolar Concentration | 2 | 2018 | 169 | 0.190 |
Why?
| | Cognition | 2 | 2020 | 990 | 0.190 |
Why?
| | Follicular Phase | 1 | 2020 | 36 | 0.180 |
Why?
| | Delaware | 1 | 2020 | 3 | 0.180 |
Why?
| | Natriuresis | 1 | 2020 | 8 | 0.180 |
Why?
| | Whey Proteins | 1 | 2020 | 5 | 0.180 |
Why?
| | Exercise Test | 3 | 2021 | 547 | 0.170 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2020 | 47 | 0.170 |
Why?
| | Menstrual Cycle | 1 | 2020 | 108 | 0.170 |
Why?
| | Blood Volume | 1 | 2020 | 57 | 0.170 |
Why?
| | Elasticity | 1 | 2020 | 188 | 0.160 |
Why?
| | Independent Living | 1 | 2020 | 84 | 0.160 |
Why?
| | Sciatic Nerve | 1 | 2019 | 56 | 0.160 |
Why?
| | Cardiorespiratory Fitness | 1 | 2019 | 35 | 0.160 |
Why?
| | Antioxidants | 1 | 2022 | 529 | 0.160 |
Why?
| | Interleukin-6 | 1 | 2022 | 673 | 0.150 |
Why?
| | Meals | 1 | 2019 | 105 | 0.150 |
Why?
| | Vasoconstriction | 1 | 2019 | 177 | 0.150 |
Why?
| | Aorta | 1 | 2020 | 388 | 0.140 |
Why?
| | Infusions, Intravenous | 1 | 2018 | 370 | 0.140 |
Why?
| | Physical Conditioning, Animal | 1 | 2019 | 194 | 0.140 |
Why?
| | Running | 1 | 2019 | 207 | 0.140 |
Why?
| | Heart Failure | 2 | 2021 | 1958 | 0.130 |
Why?
| | Dietary Supplements | 1 | 2020 | 459 | 0.130 |
Why?
| | Middle Aged | 5 | 2022 | 26605 | 0.130 |
Why?
| | Oxygen Consumption | 1 | 2019 | 587 | 0.130 |
Why?
| | Plasma | 1 | 2017 | 181 | 0.130 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2019 | 409 | 0.130 |
Why?
| | Oxidative Stress | 1 | 2022 | 1068 | 0.130 |
Why?
| | Heart-Assist Devices | 1 | 2021 | 500 | 0.120 |
Why?
| | Pulse Wave Analysis | 1 | 2015 | 207 | 0.120 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 1836 | 0.120 |
Why?
| | Biomarkers | 2 | 2022 | 3397 | 0.110 |
Why?
| | Echocardiography | 1 | 2015 | 569 | 0.100 |
Why?
| | Adolescent | 3 | 2022 | 17800 | 0.100 |
Why?
| | Adaptation, Physiological | 1 | 2015 | 484 | 0.100 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 4402 | 0.100 |
Why?
| | Ultrasonography | 1 | 2014 | 635 | 0.090 |
Why?
| | Hypercapnia | 2 | 2021 | 50 | 0.090 |
Why?
| | Hypoxia | 1 | 2016 | 956 | 0.090 |
Why?
| | Carbon Dioxide | 2 | 2021 | 218 | 0.080 |
Why?
| | Age Factors | 3 | 2020 | 2885 | 0.080 |
Why?
| | Body Size | 1 | 2023 | 90 | 0.050 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 1 | 2022 | 35 | 0.050 |
Why?
| | Lipocalin-2 | 1 | 2022 | 61 | 0.050 |
Why?
| | Kidney Function Tests | 1 | 2022 | 140 | 0.050 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2021 | 42 | 0.050 |
Why?
| | Valsalva Maneuver | 1 | 2021 | 10 | 0.050 |
Why?
| | Water-Electrolyte Balance | 1 | 2020 | 26 | 0.040 |
Why?
| | Drinking | 1 | 2020 | 33 | 0.040 |
Why?
| | Ischemia | 1 | 2023 | 361 | 0.040 |
Why?
| | Renal Elimination | 1 | 2020 | 6 | 0.040 |
Why?
| | Creatinine | 1 | 2022 | 424 | 0.040 |
Why?
| | Medulla Oblongata | 1 | 2019 | 33 | 0.040 |
Why?
| | Dietary Carbohydrates | 1 | 2020 | 138 | 0.040 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2019 | 61 | 0.040 |
Why?
| | Dehydration | 1 | 2019 | 40 | 0.040 |
Why?
| | Vasoconstrictor Agents | 1 | 2019 | 113 | 0.040 |
Why?
| | Glutamic Acid | 1 | 2019 | 210 | 0.040 |
Why?
| | Monitoring, Physiologic | 1 | 2019 | 248 | 0.040 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2016 | 29 | 0.030 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2016 | 47 | 0.030 |
Why?
| | Dehydroepiandrosterone Sulfate | 1 | 2016 | 45 | 0.030 |
Why?
| | Dehydroepiandrosterone | 1 | 2016 | 49 | 0.030 |
Why?
| | Saliva | 1 | 2016 | 188 | 0.030 |
Why?
| | Reaction Time | 1 | 2016 | 373 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 2182 | 0.030 |
Why?
| | Diet | 1 | 2021 | 1080 | 0.030 |
Why?
| | Memory, Short-Term | 1 | 2016 | 227 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 1706 | 0.030 |
Why?
| | Prefrontal Cortex | 1 | 2016 | 263 | 0.030 |
Why?
| | Rats | 1 | 2019 | 4913 | 0.020 |
Why?
| | Animals | 2 | 2020 | 31565 | 0.020 |
Why?
|
|
Babcock's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|